EG
Eagle Pharmaceuticals, Inc.
EGRX · OTC
$0.18 +11.59% (+$0.02)
1M +143.40%
Piotroski F-Score Moderate
4/9Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
-
N/A ROIC N/A
Asset turnover N/A
ROE N/A
Debt
-
N/A Debt/Equity N/A
Debt/Assets N/A
Current ratio N/A
Stability
100 /100
Stable Beta 0.66x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre EGRX
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Michael Graves
Employees
135
Headquarters
Woodcliff Lake
Evenimente viitoare
09 NOV.
Earnings
Upcoming earnings report